LPL Financial’s Alnylam Pharmaceuticals ALNY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$22.4M Buy
67,637
+21,718
+47% +$7.39M 0.01% 1389
2025
Q4
$18.3M Sell
45,919
-2,561
-5% -$1.13M 0.01% 1469
2025
Q3
$22.1M Buy
48,480
+18,141
+60% +$7.39M 0.01% 1305
2025
Q2
$9.89M Buy
30,339
+9,660
+47% +$2.67M ﹤0.01% 1722
2025
Q1
$5.58M Buy
20,679
+2,107
+11% +$541K ﹤0.01% 2060
2024
Q4
$4.37M Sell
18,572
-234
-1% -$61.5K ﹤0.01% 2192
2024
Q3
$5.17M Buy
18,806
+170
+0.9% +$44.3K ﹤0.01% 1964
2024
Q2
$4.53M Buy
18,636
+1,662
+10% +$262K ﹤0.01% 1939
2024
Q1
$2.54M Buy
16,974
+253
+2% +$42.2K ﹤0.01% 2330
2023
Q4
$3.2M Buy
16,721
+951
+6% +$162K ﹤0.01% 2031
2023
Q3
$2.79M Buy
15,770
+895
+6% +$171K ﹤0.01% 2027
2023
Q2
$2.83M Buy
14,875
+165
+1% +$32.7K ﹤0.01% 1968
2023
Q1
$2.95M Buy
14,710
+925
+7% +$194K ﹤0.01% 1852
2022
Q4
$3.28M Buy
13,785
+547
+4% +$117K ﹤0.01% 1711
2022
Q3
$2.65M Buy
13,238
+1,455
+12% +$278K ﹤0.01% 1783
2022
Q2
$1.72M Sell
11,783
-4,825
-29% -$685K ﹤0.01% 2144
2022
Q1
$2.71M Buy
16,608
+714
+4% +$109K ﹤0.01% 1827
2021
Q4
$2.69M Buy
15,894
+2,792
+21% +$519K ﹤0.01% 1871
2021
Q3
$2.47M Buy
13,102
+2,858
+28% +$536K ﹤0.01% 1890
2021
Q2
$1.74M Buy
10,244
+1,143
+13% +$167K ﹤0.01% 2091
2021
Q1
$1.28M Buy
9,101
+3,519
+63% +$530K ﹤0.01% 2180
2020
Q4
$725K Sell
5,582
-98
-2% -$13.1K ﹤0.01% 2439
2020
Q3
$827K Buy
5,680
+360
+7% +$51.2K ﹤0.01% 2090
2020
Q2
$788K Buy
5,320
+577
+12% +$77.8K ﹤0.01% 2025
2020
Q1
$516K Buy
4,743
+108
+2% +$12.5K ﹤0.01% 2075
2019
Q4
$534K Buy
4,635
+280
+6% +$27.9K ﹤0.01% 2323
2019
Q3
$350K Sell
4,355
-874
-17% -$69.1K ﹤0.01% 2549
2019
Q2
$379K Buy
5,229
+857
+20% +$65.8K ﹤0.01% 2501
2019
Q1
$409K Buy
4,372
+1,331
+44% +$111K ﹤0.01% 2382
2018
Q4
$222K Sell
3,041
-892
-23% -$68.6K ﹤0.01% 2728
2018
Q3
$344K Buy
3,933
+176
+5% +$17.7K ﹤0.01% 2555
2018
Q2
$370K Buy
3,757
+107
+3% +$10.6K ﹤0.01% 2456
2018
Q1
$435K Buy
3,650
+958
+36% +$124K ﹤0.01% 2280
2017
Q4
$342K Sell
2,692
-126
-4% -$15.8K ﹤0.01% 2376
2017
Q3
$331K Buy
+2,818
New +$241K ﹤0.01% 2280
2016
Q2
Sell
-4,098
Closed -$280K 2633
2016
Q1
$280K Sell
4,098
-17,650
-81% -$1.17M ﹤0.01% 2563
2015
Q4
$2.06M Buy
21,748
+10,779
+98% +$999K 0.01% 1150
2015
Q3
$880K Buy
10,969
+2,280
+26% +$253K ﹤0.01% 1331
2015
Q2
$1.03M Buy
8,689
+115
+1% +$13.7K 0.01% 1346
2015
Q1
$902K Buy
8,574
+560
+7% +$56.7K ﹤0.01% 1424
2014
Q4
$777K Sell
8,014
-62
-0.8% -$5.74K ﹤0.01% 1490
2014
Q3
$622K Hold
8,076
﹤0.01% 1619
2014
Q2
$510K Sell
8,076
-8,558
-51% -$509K ﹤0.01% 1788
2014
Q1
$1.12M Buy
16,634
+3,746
+29% +$290K 0.01% 1196
2013
Q4
$829K Buy
12,888
+5,369
+71% +$320K 0.01% 1363
2013
Q3
$447K Sell
7,519
-132
-2% -$6.58K ﹤0.01% 1734
2013
Q2
$237K Buy
+7,651
New +$204K ﹤0.01% 2077

Other funds holding ALNY